Regulation & law · 16/11/2015
MannKind Corporation Proposes Production of Inhalable Insulin in Connecticut FTZ 76-Bridgeport
MannKind Corporation has submitted a notification to the U.S. Foreign-Trade Zone (FTZ) 76-Bridgeport, Connecticut, for proposed production of its inhalable insulin product, in Danbury, Connecticut.
Original source language: Federal Register — All DocumentsOpen original release →
Related company profile: AlabOpen profile →Explore businesses on Business Maps →